Meenakshi Jain, MD
Gynecology · St Petersburg, FLNPI 1467409037
Payments from drug & device makers
What this record shows
This record is dominated by education: $29,259 of the $35,372 with a category attached, or 82.7%. Intuitive Surgical accounts for 87.6% of it on its own, with 32 other manufacturers making up the rest. 2025 is the largest year on record at $18,492, more than ten times the $1,336 reported in 2019. Among gynecology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $153.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$31K
- Axonics, Inc.$2K
- AbbVie$503
- Astellas Pharma US Inc$383
- Exeltis, USA Inc.$227
- Millicent US Inc$193
- plus $1K from 27 others
What the payments were for
- Speaking & faculty fees$1600%
- Travel & lodging$6252%
- Food & beverage$5,12514%
- Education$29,25983%
- Gifts$2031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 45 | $30,978 |
| Axonics, Inc. | 48 | $1,684 |
| AbbVie(2 entities) | 29 | $503 |
| Astellas Pharma US Inc | 13 | $383 |
| Exeltis, USA Inc. | 13 | $227 |
| Millicent US Inc | 11 | $193 |
| Mayne Pharma Commercial LLC | 11 | $171 |
| Boston Scientific | 1 | $142 |
| Pfizer | 8 | $138 |
| Femselect Inc. | 1 | $120 |
| Myovant Sciences Inc. | 7 | $111 |
| Medtronic(2 entities) | 5 | $81 |
| Therapeuticsmd, Inc. | 4 | $64 |
| Avion Pharmaceuticals | 4 | $57 |
| Sumitomo Pharma America, Inc. | 3 | $54 |
| Ascend Therapeutics US, LLC | 3 | $53 |
| AMAG Pharmaceuticals, Inc. | 4 | $50 |
| Coloplast | 2 | $41 |
| Shield Therapeutics Inc | 2 | $38 |
| Evofem Biosciences, Inc. | 2 | $34 |
| Vertical Pharmaceuticals, LLC | 2 | $32 |
| Channel Medsystems, Inc. | 1 | $27 |
| Dysis Medical, Inc. | 1 | $26 |
| Mimedx Group, Inc. | 1 | $23 |
| Amgen | 1 | $20 |
| Conmed Corporation | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Gynesonics, Inc. | 1 | $14 |
| Lupin Inc. | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
| Mission Pharmacal Company | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$30,248
- Axonics r-SNM System$228
- Axonics$142
- EnPlace$120
How this compares
$35,372 in reported general payments places this provider in the 95th percentile of 290 gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 25 | $19,144 |
| PremarinEstrogens, Conjugated | 30 | $11,034 |
| Estradiol | 47 | $3,976 |
| YuvafemEstradiol | 20 | $3,386 |
| Oxybutynin Chloride ErOxybutynin Chloride | 33 | $1,798 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 44 | $1,659 |
| NitrofurantoinNitrofurantoin Macrocrystal | 61 | $1,201 |
| ValacyclovirValacyclovir Hcl | 29 | $1,100 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 81 | $749 |
| Metronidazole | 53 | $639 |
| Clobetasol Propionate | 15 | $522 |
| Ciprofloxacin Hcl | 40 | $305 |
| Doxycycline Hyclate | 42 | $294 |
| Norethindrone | 11 | $290 |
| Tamsulosin Hcl | 25 | $237 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $383 | $19,14425 claims |
| PfizerPremarin | $138 | $11,03430 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 290 gynecology providers in Florida.
Other gynecology in St Petersburg
- Aileen CaceresKissimmee$406K
- Parveen VahoraNew Port Richey$327K
- James KondrupVenice$310K
- Andrea GallowayThe Villages$252K
- Jessica VaughtOrlando$129K
- Steven ChavoustieMiami$113K
- Marshall BovelskyMelbourne$52K
- Minda NeimarkFt Lauderdale$46K
- Michael SpragueWeston$34K
- Nashat MoawadGainesville$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.